Patents by Inventor Raymond G. Booth

Raymond G. Booth has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Serotonin receptor-targeting compounds and methods
    Patent number: 11021435
    Abstract: This invention relates to, in part, compositions and methods that are useful for, inter alia, the treatment of various diseases, including those linked to binding at a serotonin receptor. The compositions include chiral tetrahydronaphthalen-2-amine derivatives. Accordingly, the present invention provides for compositions and methods that agonize or antagonize one or more serotonin receptors and which find Use in the treatment of various neuropsychiatric diseases or disorders including, without limitation, autism spectrum disorder (ASD) or associated symptoms.
    Type: Grant
    Filed: May 19, 2015
    Date of Patent: June 1, 2021
    Assignee: Northeastern University
    Inventor: Raymond G. Booth
  • THERAPEUTIC COMPOUNDS AND METHODS OF USE
    Publication number: 20200115320
    Abstract: The invention relates to protein binding interacting/binding compounds and methods of identifying and using them. The invention further relates to pharmaceutical compositions and methods for treating 5-HT2C disorders, including diseases and disorders mediated by GPCRs.
    Type: Application
    Filed: July 24, 2019
    Publication date: April 16, 2020
    Applicant: University of Florida Research Foundation, Incorporated
    Inventor: Raymond G. Booth
  • Compounds and methods for modulating serotonin receptors in the periphery
    Patent number: 10548856
    Abstract: This invention relates to, in part, compositions and methods that are useful for, inter alia, the treatment of various diseases, including those linked to binding at a serotonin receptor in the GI tract.
    Type: Grant
    Filed: May 19, 2016
    Date of Patent: February 4, 2020
    Assignee: Northeastern University
    Inventor: Raymond G. Booth
  • THERAPEUTIC COMPOUNDS AND METHODS OF USE
    Publication number: 20180194716
    Abstract: The invention relates to protein biding interacting/binding compounds and methods of identifying and using them. The invention further relates to pharmaceutical compositions and methods for treating 5-HT2C disorders, including diseases and disorders mediated by GPCRs.
    Type: Application
    Filed: January 8, 2018
    Publication date: July 12, 2018
    Inventor: Raymond G. Booth
  • Therapeutic tetrahydronaphthalene compounds
    Patent number: 10017458
    Abstract: The invention relates to protein binding interacting/binding compounds and methods of identifying and using them. The invention further relates to pharmaceutical compositions and methods for treating 5-HT2C and/or RSK disorders, including diseases and disorders mediated by CPCRs and/or RSKs.
    Type: Grant
    Filed: March 23, 2015
    Date of Patent: July 10, 2018
    Assignee: University of Florida Research Foundation, Incorporated
    Inventor: Raymond G. Booth
  • Compounds and Methods for Modulating Serotonin Receptors in the Periphery
    Publication number: 20180125798
    Abstract: This invention relates to, in part, compositions and methods that are useful for, inter alia, the treatment of various diseases, including those linked to binding at a serotonin receptor in the GI tract.
    Type: Application
    Filed: May 19, 2016
    Publication date: May 10, 2018
    Inventor: Raymond G. BOOTH
  • Therapeutic compounds and methods of use
    Patent number: 9862674
    Abstract: The invention relates to protein binding interacting/binding compounds and methods of identifying and using them. The invention further relates to pharmaceutical compositions and methods for treating 5-HT2C disorders, including diseases and disorders mediated by GPCRs.
    Type: Grant
    Filed: September 22, 2015
    Date of Patent: January 9, 2018
    Assignee: University of Florida Research Foundation, Incorporated
    Inventor: Raymond G. Booth
  • Serotonin Receptor-Targeting Compounds and Methods
    Publication number: 20170081273
    Abstract: This invention relates to, in part, compositions and methods that are useful for, inter alia, the treatment of various diseases, including those linked to binding at a serotonin receptor. The compositions include chiral tetrahydronaphthalen-2-amine derivatives. Accordingly, the present invention provides for compositions and methods that agonize or antagonize one or more serotonin receptors and which find Use in the treatment of various neuropsychiatric diseases or disorders including, without limitation, autism spectrum disorder (ASD) or associated symptoms.
    Type: Application
    Filed: May 19, 2015
    Publication date: March 23, 2017
    Inventor: Raymond G. Booth
  • Therapeutic compounds
    Patent number: 9422229
    Abstract: The invention relates to protein binding interacting/binding compounds and methods of identifying and using them. The invention further relates to pharmaceutical compositions and methods for treating 5-HT2C disorders, including diseases and disorders mediated by GPCRs.
    Type: Grant
    Filed: November 19, 2013
    Date of Patent: August 23, 2016
    Assignee: University of Florida Research Foundation, Inc.
    Inventor: Raymond G. Booth
  • THERAPEUTIC COMPOUNDS AND METHODS OF USE
    Publication number: 20160145194
    Abstract: The invention relates to protein binding interacting/binding compounds and methods of identifying and using them. The invention further relates to pharmaceutical compositions and methods for treating 5-HT2C disorders, including diseases and disorders mediated by GPCRs.
    Type: Application
    Filed: September 22, 2015
    Publication date: May 26, 2016
    Inventor: Raymond G. Booth
  • THERAPEUTIC COMPOUNDS
    Publication number: 20150315127
    Abstract: The invention relates to protein binding interacting/binding compounds and methods of identifying and using them. The invention further relates to pharmaceutical compositions and methods for treating 5-HT2C and/or RSK disorders, including diseases and disorders mediated by GPCRs and/or RSKs.
    Type: Application
    Filed: March 23, 2015
    Publication date: November 5, 2015
    Inventor: Raymond G. Booth
  • Therapeutic compounds
    Patent number: 9024071
    Abstract: The invention relates to protein binding interacting/binding compounds and methods of identifying and using them. The invention further relates to pharmaceutical compositions and methods for treating 5-HT2C and/or RSK disorders, including diseases and disorders mediated by GPCRs and/or RSKs.
    Type: Grant
    Filed: May 5, 2010
    Date of Patent: May 5, 2015
    Assignee: University of Florida Research Foundation, Inc.
    Inventor: Raymond G. Booth
  • THERAPEUTIC COMPOUNDS
    Publication number: 20140155490
    Abstract: The invention relates to protein binding interacting/binding compounds and methods of identifying and using them. The invention further relates to pharmaceutical compositions and methods for treating 5-HT2C disorders, including diseases and disorders mediated by GPCRs.
    Type: Application
    Filed: November 19, 2013
    Publication date: June 5, 2014
    Applicant: University of Florida Research Foundation, Inc.
    Inventor: Raymond G. Booth
  • Therapeutic compounds
    Patent number: 8586634
    Abstract: The invention relates to protein binding interacting/binding compounds and methods of identifying and using them. The invention further relates to pharmaceutical compositions and methods for treating 5-HT2C disorders, including diseases and disorders mediated by GPCRs.
    Type: Grant
    Filed: June 13, 2008
    Date of Patent: November 19, 2013
    Assignee: University of Florida Research Foundation, Inc.
    Inventor: Raymond G. Booth
  • THERAPEUTIC COMPOUNDS
    Publication number: 20120149693
    Abstract: The invention relates to protein binding interacting/binding compounds and methods of identifying and using them. The invention further relates to pharmaceutical compositions and methods for treating 5-HT2C and/or RSK disorders, including diseases and disorders mediated by GPCRs and/or RSKs.
    Type: Application
    Filed: May 5, 2010
    Publication date: June 14, 2012
    Applicant: UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC.
    Inventor: Raymond G. Booth
  • THERAPEUTIC COMPOUNDS
    Publication number: 20100305212
    Abstract: The invention relates to protein binding interacting/binding compounds and methods of identifying and using them. The invention further relates to pharmaceutical compositions and methods for treating 5-HT2C disorders, including diseases and disorders mediated by GPCRs.
    Type: Application
    Filed: June 13, 2008
    Publication date: December 2, 2010
    Applicant: University of Florida Research Foundation, Inc.
    Inventor: Raymond G. Booth
  • THERAPEUTIC COMPOUNDS AND METHODS OF USE
    Publication number: 20100227934
    Abstract: The invention relates to protein binding interacting/binding compounds and methods of identifying and using them. The invention further relates to pharmaceutical compositions and methods for treating 5-HT2C disorders, including diseases and disorders mediated by GPCRs.
    Type: Application
    Filed: June 13, 2008
    Publication date: September 9, 2010
    Applicant: University of Florida Research Foundation, Inc
    Inventor: Raymond G. Booth